Medicines Safety Improvement Programme

Published on 1 December 2021

About the programme

The Medicines Safety Improvement Programme (MedSIP) aims to help patients get the maximum benefit from their medicines and reduce waste, with an overarching aim to reduce medication related harm in health and social care, focusing on high risk drugs, situations and vulnerable patients.

Each area of work in this programme intends to make medicines safety part of routine practice, ensure medicines use is as safe as possible and understand the patients’ experience.

Programme ambitions

The projects that are currently included in the work programme for the next 12 months aim to:

Reduce medicine administration errors in care homes.

Reduce harm from opioid medicines by reducing high dose prescribing (>120mg oral Morphine equivalent), for non-cancer pain.

Reduce harm by reducing the prescription and supply of oral methotrexate 10mg.

Find out more

Further information on projects relating to MedSIP programme can be found by clicking on the links below.

Alternatively, please get in touch with a member of the programme team below to find out how you can get involved.


Project team

Caroline Maries-Tillott

Quality Improvement Lead

Amandeep Bhandal

Assistant Programme Manager (Medicines Safety)

Emma Suggett

Medicines Optimisation Lead

Related Projects

  • Emergency Laparotomy (EmLap) Collaborative

    discover more
  • Asthma Discharge Bundle

    discover more
  • COPD Discharge Bundle

    discover more